To include your compound in the COVID-19 Resource Center, submit it here.

Democrats ask NIH for Xtandi march-in hearing

A group of 12 U.S. House and Senate Democrats sent a Xtandi enzalutamide from Astellas Pharma Inc. (Tokyo:4503).

In January, two patient advocacy groups asked

Read the full 259 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE